TY - JOUR
T1 - Lack of Early Improvement Predicts Poor Outcome Following Acute Intracerebral Hemorrhage
AU - (VISTA)-ICH Collaborators
AU - Yogendrakumar, Vignan
AU - Smith, Eric E.
AU - Demchuk, Andrew M.
AU - Aviv, Richard I.
AU - Rodriguez-Luna, David
AU - Molina, Carlos A.
AU - Blas, Yolanda Silva
AU - Dzialowski, Imanuel
AU - Kobayashi, Adam
AU - Boulanger, Jean Martin
AU - Lum, Cheemun
AU - Gubitz, Gord
AU - Padma, Vasantha
AU - Roy, Jayanta
AU - Kase, Carlos S.
AU - Bhatia, Rohit
AU - Ali, Myzoon
AU - Lyden, Patrick
AU - Hill, Michael D.
AU - Dowlatshahi, Dar
AU - Hanley, Daniel F.
AU - Butcher, Ken
AU - Davis, Stephen M.
AU - Gregson, B.
AU - Lees, Kennedy R.
AU - Lyden, Patrick
AU - Mayer, S.
AU - Muir, Keith
AU - Steiner, Thor Sten
N1 - Funding Information:
Dr. Demchuk’s institution received funding from Canadian Stroke Consortium and NovoNordisk Canada, and he disclosed off-label product use of recombinant factor VIIa (administered for intracerebral hemorrhage in a limited fashion within the PREDICT study). Dr. Aviv received support for article research from the Canadian Institutes of Health Research. Dr. Lyden’s institution received funding from the National Institute of Health (National Institute of Neurological Disorders and Stroke), and he received funding from expert testimony. Dr. Hill disclosed that the PREDICT study was supported by a grant from the Canadian Stroke Consortium. Dr. Dow-latshahi was funded by a uOttawa Department of Medicine Clinician-Scientist Research Chair award and a Heart & Stroke Foundation of Canada New Investigator Award. Dr. Dowlatshahi received funding from Bayer Canada, BMS/Pfizer, and Boerhinger Ingleheim. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: [email protected]
Publisher Copyright:
Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2018
Y1 - 2018
N2 - Objectives: There are limited data as to what degree of early neurologic change best relates to outcome in acute intracerebral hemorrhage. We aimed to derive and validate a threshold for early postintracerebral hemorrhage change that best predicts 90-day outcomes. Design: Derivation: retrospective analysis of collated clinical stroke trial data (Virtual International Stroke Trials Archive). Validation: retrospective analysis of a prospective multicenter cohort study (Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign [PREDICT]). Setting: Neurocritical and ICUs. Patients: Patients with acute intracerebral hemorrhage presenting less than 6 hours. Derivation: 552 patients; validation: 275 patients. Interventions: None. Measurements and Main Results: We generated a receiver operating characteristic curve for the association between 24-hour National Institutes of Health Stroke Scale change and clinical outcome. The primary outcome was a modified Rankin Scale score of 4–6 at 90 days; secondary outcomes were other modified Rankin Scale score ranges (modified Rankin Scale, 2–6, 3–6, 5–6, 6). We employed Youden’s J Index to select optimal cut points and calculated sensitivity, specificity, and predictive values. We determined independent predictors via multivariable logistic regression. The derived definitions were validated in the PREDICT cohort. Twenty-four–hour National Institutes of Health Stroke Scale change was strongly associated with 90-day outcome with an area under the receiver operating characteristic curve of 0.75. Youden’s method showed an optimum cut point at –0.5, corresponding to National Institutes of Health Stroke Scale change of greater than or equal to 0 (a lack of clinical improvement), which was seen in 46%. Early neurologic change accurately predicted poor outcome when defined as greater than or equal to 0 (sensitivity, 65%; specificity, 73%; positive predictive value, 70%; adjusted odds ratio, 5.05 [CI, 3.25–7.85]) or greater than or equal to 4 (sensitivity, 19%; specificity, 98%; positive predictive value, 91%; adjusted odds ratio, 12.24 [CI, 4.08–36.66]). All definitions reproduced well in the validation cohort. Conclusions: Lack of clinical improvement at 24 hours robustly predicted poor outcome and showed good discrimination for individual patients who would do poorly. These findings are useful for prognostication and may also present as a potential early surrogate outcome for future intracerebral hemorrhage treatment trials.
AB - Objectives: There are limited data as to what degree of early neurologic change best relates to outcome in acute intracerebral hemorrhage. We aimed to derive and validate a threshold for early postintracerebral hemorrhage change that best predicts 90-day outcomes. Design: Derivation: retrospective analysis of collated clinical stroke trial data (Virtual International Stroke Trials Archive). Validation: retrospective analysis of a prospective multicenter cohort study (Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign [PREDICT]). Setting: Neurocritical and ICUs. Patients: Patients with acute intracerebral hemorrhage presenting less than 6 hours. Derivation: 552 patients; validation: 275 patients. Interventions: None. Measurements and Main Results: We generated a receiver operating characteristic curve for the association between 24-hour National Institutes of Health Stroke Scale change and clinical outcome. The primary outcome was a modified Rankin Scale score of 4–6 at 90 days; secondary outcomes were other modified Rankin Scale score ranges (modified Rankin Scale, 2–6, 3–6, 5–6, 6). We employed Youden’s J Index to select optimal cut points and calculated sensitivity, specificity, and predictive values. We determined independent predictors via multivariable logistic regression. The derived definitions were validated in the PREDICT cohort. Twenty-four–hour National Institutes of Health Stroke Scale change was strongly associated with 90-day outcome with an area under the receiver operating characteristic curve of 0.75. Youden’s method showed an optimum cut point at –0.5, corresponding to National Institutes of Health Stroke Scale change of greater than or equal to 0 (a lack of clinical improvement), which was seen in 46%. Early neurologic change accurately predicted poor outcome when defined as greater than or equal to 0 (sensitivity, 65%; specificity, 73%; positive predictive value, 70%; adjusted odds ratio, 5.05 [CI, 3.25–7.85]) or greater than or equal to 4 (sensitivity, 19%; specificity, 98%; positive predictive value, 91%; adjusted odds ratio, 12.24 [CI, 4.08–36.66]). All definitions reproduced well in the validation cohort. Conclusions: Lack of clinical improvement at 24 hours robustly predicted poor outcome and showed good discrimination for individual patients who would do poorly. These findings are useful for prognostication and may also present as a potential early surrogate outcome for future intracerebral hemorrhage treatment trials.
KW - critical care
KW - intracranial hemorrhage
KW - mortality/ survival
KW - prognosis
KW - quality and outcomes
UR - http://www.scopus.com/inward/record.url?scp=85055727900&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000002962
DO - 10.1097/CCM.0000000000002962
M3 - Article
C2 - 29303797
AN - SCOPUS:85055727900
SN - 0090-3493
VL - 46
SP - E310-E317
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 4
ER -